well, certainly the hard part about a stock like MCET is not to determine what it's real value is or should be but to determine what value is placed upon it by "the market", that is, the sometimes somewhat unsophisticated, lacking in bio savvy day trader who sees the words "stem cell patent" and immediately thinks that the stock is going "to da moon!" and that big pharma has nothing but big bags o cash to hand out to anybody with a "stem cell patent".
Never mind that, for example, the patent in question is not actually held by MCET but by Rhode Island Hospital. I am sure somebody here has details on the licensing terms? I can't find any.
News 
Market Data 
Discover 
AI
